相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy
Mohammad Reza Karimzadeh et al.
CANCER GENE THERAPY (2021)
Methods for analysis of specific DNA methylation status
Maria J. Pajares et al.
METHODS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
Alex H. Krist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Multiple microRNAs as biomarkers for early breast cancer diagnosis
Ji Young Jang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2021)
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
MaryBeth B. Culp et al.
EUROPEAN UROLOGY (2020)
Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer
Emre Ozgur et al.
CANCER BIOMARKERS (2020)
Circulating microRNAs predict the response to anti-PD-1 therapy in non-small cell lung cancer
Jinshuo Fan et al.
GENOMICS (2020)
Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer
Wei Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Screening for Colon Cancer in Older Adults: Risks, Benefits, and When to Stop
Judy Nee et al.
MAYO CLINIC PROCEEDINGS (2020)
A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade
Thomas Hermanns et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
Tobias Fehlmann et al.
JAMA ONCOLOGY (2020)
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
Vera Constancio et al.
CELLS (2020)
Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients
Patricia M. M. Ozawa et al.
BIOMOLECULES (2020)
Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non-Small Cell Lung Cancer
Bin Liu et al.
CLINICAL CANCER RESEARCH (2020)
Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
Yi Liu et al.
FRONTIERS IN GENETICS (2020)
SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis
Mehdi Manoochehri et al.
MOLECULAR ONCOLOGY (2020)
Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients
Roxana Cojocneanu et al.
CANCERS (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Current status of development of methylation biomarkers for in vitro diagnostic IVD applications
Olga Taryma-Lesniak et al.
CLINICAL EPIGENETICS (2020)
Aberrant DNA Methylation ofSEPT9andSDC2in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
Guodong Zhao et al.
FRONTIERS IN GENETICS (2020)
Plasma Level of Circular RNA hsa_circ_0000190 Correlates with Tumor Progression and Poor Treatment Response in Advanced Lung Cancers
Yung-Hung Luo et al.
CANCERS (2020)
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
Pier Vitale Nuzzo et al.
NATURE MEDICINE (2020)
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
Farshad Nassiri et al.
NATURE MEDICINE (2020)
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
Xingdong Chen et al.
NATURE COMMUNICATIONS (2020)
A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery
Jessica Gasparello et al.
CANCERS (2020)
Liquid biopsies and cancer omics
Ivano Amelio et al.
CELL DEATH DISCOVERY (2020)
A Pilot Study Comparing the Efficacy of Lactate Dehydrogenase Levels Versus Circulating Cell-Free microRNAs in Monitoring Responses to Checkpoint Inhibitor Immunotherapy in Metastatic Melanoma Patients
Matias A. Bustos et al.
CANCERS (2020)
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer
Carmen Salvador-Coloma et al.
EUROPEAN JOURNAL OF CANCER (2020)
Modern biomarkers in prostate cancer diagnosis
Pawel Porzycki et al.
CENTRAL EUROPEAN JOURNAL OF UROLOGY (2020)
A Panel of Urinary Long Non-coding RNAs Differentiate Bladder Cancer from Urocystitis
Xiao Yu et al.
JOURNAL OF CANCER (2020)
Epidemiology of Renal Cell Carcinoma
Sandeep Anand Padala et al.
WORLD JOURNAL OF ONCOLOGY (2020)
Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
Tim C. de Ruijter et al.
BREAST CANCER RESEARCH (2020)
Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery
Francisco Exposito et al.
CANCER LETTERS (2019)
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
Fumihiko Urabe et al.
CLINICAL CANCER RESEARCH (2019)
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Luis M. Seijo et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
Irene Li et al.
MOLECULAR CANCER (2019)
Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer
Marta Herreros-Villanueva et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations
Haixin Yu et al.
CANCERS (2019)
A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers
Hanshao Liu et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Is global hypomethylation a nidus for molecular pathogenesis of age-related noncommunicable diseases?
Apiwat Mutirangura
EPIGENOMICS (2019)
Analysis of circulating non-coding RNAs in a non-invasive and cost-effective manner
Yu-Min Wang et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2019)
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
Laura M. Doyle et al.
CELLS (2019)
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology
Giovanni Ponti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening
Guodong Zhao et al.
CANCER MEDICINE (2019)
DNA Methylation Cancer Biomarkers: Translation to the Clinic
Warwick J. Locke et al.
FRONTIERS IN GENETICS (2019)
Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors
Alena Kopkova et al.
CANCERS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection
Maurizia Mello-Grand et al.
CARCINOGENESIS (2019)
Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer
Sho Shiino et al.
CLINICAL CANCER RESEARCH (2019)
Overexpression of circulating MiR-30b-5p identifies advanced breast cancer
Helena Estevao-Pereira et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
The Circulating Transcriptome as a Source of Biomarkers for Melanoma
Carla Sole et al.
CANCERS (2019)
Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy
Oscar Rapado-Gonzalez et al.
CELLS (2019)
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer
Paola Ulivi et al.
JOURNAL OF CLINICAL MEDICINE (2019)
High-throughput and ultra-sensitive single-cell profiling of multiple microRNAs and identification of human cancer
Lu Li et al.
CHEMICAL COMMUNICATIONS (2019)
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer
Eve O'Reilly et al.
JCO PRECISION ONCOLOGY (2019)
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
Ludovic Barault et al.
GUT (2018)
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
Oliver A. Zill et al.
CLINICAL CANCER RESEARCH (2018)
Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
Lydia Giannopoulou et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
GSTP1 methylation in cancer: a liquid biopsy biomarker?
Giorgia Gurioli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients
Magdalena Absmaier et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition
Pawel Porzycki et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2018)
The Role of DNA Methylation in Renal Cell Carcinoma
Brittany N. Lasseigne et al.
MOLECULAR DIAGNOSIS & THERAPY (2018)
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
Christa Haldrup et al.
MOLECULAR ONCOLOGY (2018)
Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer
Yujiao Xie et al.
MOLECULAR ONCOLOGY (2018)
The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer
Simon Ladefoged Rasmussen et al.
Oncotarget (2018)
A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples o
Maria Gallardo-Gomez et al.
CLINICAL EPIGENETICS (2018)
Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection
Yu Wang et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis
Jagdeep Singh Bhangu et al.
ANNALS OF SURGERY (2018)
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
Fang Zhao et al.
CLINICAL EPIGENETICS (2018)
Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
Catarina Moreira-Barbosa et al.
CLINICAL EPIGENETICS (2018)
Analysis of blood markers for early breast cancer diagnosis
J. Bayo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
Alicia Hulbert et al.
CLINICAL CANCER RESEARCH (2017)
Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer
W. Wang et al.
EUROPEAN JOURNAL OF CANCER CARE (2017)
Plasma and saliva miR-21 expression in colorectal cancer patients
A. A. Sazanov et al.
JOURNAL OF APPLIED GENETICS (2017)
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
Kala Visvanathan et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy
Kim E. M. van Kessel et al.
JOURNAL OF UROLOGY (2017)
Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance
Fang Zhao et al.
JOURNAL OF UROLOGY (2017)
The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection
Tomasz Powrozek et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
Colorectal cancer screening: An updated review of the available options
Iyad A. Issa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Value of the level of methylation of RASSF1A and WIF-1 in tissue and serum in neoadjuvant chemotherapeutic assessment for advanced breast cancer
Zhong-Hua Han et al.
ONCOLOGY LETTERS (2017)
Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients
Mariana Brait et al.
ONCOTARGET (2017)
The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
Qiliang Peng et al.
ONCOTARGET (2017)
Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer
Lutao Du et al.
ONCOTARGET (2017)
The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis
Di Liu et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2017)
Circulating Tumor DNA as Biomarkers for Cancer Detection
Xiao Han et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2017)
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
Peter McAnena et al.
CANCERS (2017)
Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory
Jose Luis Garcia-Gimenez et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA
Akira Ooki et al.
CLINICAL CANCER RESEARCH (2017)
Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer
Zixu Yuan et al.
BRITISH JOURNAL OF CANCER (2017)
Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer
Joseph J. Fantony et al.
CANCER BIOMARKERS (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients
T. Powrozek et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese
Yongqiang Wang et al.
ONCOTARGET (2016)
Amplification-Free Detection of Circulating microRNA Biomarkers from Body Fluids Based on Fluorogenic Oligonucleotide-Templated Reaction between Engineered Peptide Nucleic Acid Probes: Application to Prostate Cancer Diagnosis
Gavin A. D. Metcalf et al.
ANALYTICAL CHEMISTRY (2016)
Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the US Preventive Services Task Force
Joy Melnikow et al.
ANNALS OF INTERNAL MEDICINE (2016)
Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers
Yenkai Lim et al.
BMC CANCER (2016)
A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer
Angel Diaz-Lagares et al.
CLINICAL CANCER RESEARCH (2016)
SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer
Ioanna Balgkouranidou et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
New Progress of Epigenetic Biomarkers in Urological Cancer
Peng Wu et al.
DISEASE MARKERS (2016)
Epigenetic Determinants of Cancer
Stephen B. Baylin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer
Chang-Hua Kou et al.
ONCOLOGY LETTERS (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
A microRNA biomarker panel for the non-invasive detection of bladder cancer
Virginia Urquidi et al.
ONCOTARGET (2016)
Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma
Xujie Gao et al.
ONCOTARGET (2016)
A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer
Graeme P. Young et al.
CANCER MEDICINE (2016)
Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: the importance of cancer prevention in addition to cancer detection
Perry J. Pickhardt
ABDOMINAL RADIOLOGY (2016)
Considering Exosomal miR-21 as a Biomarker for Cancer
Jian Shi
JOURNAL OF CLINICAL MEDICINE (2016)
Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests
Le-Le Song et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Plasma extracellular RNA profiles in healthy and cancer patients
Tiezheng Yuan et al.
SCIENTIFIC REPORTS (2016)
Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma
Francesca Salvianti et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2016)
Methylation analyses in liquid biopsy
Delphine Lissa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
A urine-based methylation signature for risk stratification within low-risk prostate cancer
T. A. Jatkoe et al.
BRITISH JOURNAL OF CANCER (2015)
Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
T. F. Hansen et al.
BRITISH JOURNAL OF CANCER (2015)
Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation
Shuhang Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Sox17 Promoter Methylation in Plasma DNA Is Associated With Poor Survival and Can Be Used as a Prognostic Factor in Breast Cancer
Deyuan Fu et al.
MEDICINE (2015)
MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer
David A. Armstrong et al.
MOLECULAR CANCER (2015)
Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis
Sanaa Eissa et al.
TUMOR BIOLOGY (2015)
miRNA in situ hybridization in circulating tumor cells - MishCTC
Francisco G. Ortega et al.
SCIENTIFIC REPORTS (2015)
Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer
Hong Wang et al.
CLINICAL EPIGENETICS (2015)
Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
Bernd Schmidt et al.
PLOS ONE (2015)
MGMT promoter methylation in serum and cerebrospinal fluid as a tumor-specific biomarker of glioma
Zheng Wang et al.
BIOMEDICAL REPORTS (2015)
Circulating DNA as biomarker in breast cancer
Heidi Schwarzenbach et al.
BREAST CANCER RESEARCH (2015)
ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients
Joaquina Martinez-Galan et al.
BMC CANCER (2014)
Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer
I. Balgkouranidou et al.
BRITISH JOURNAL OF CANCER (2014)
HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients
Miroslav Svoboda et al.
CARCINOGENESIS (2014)
A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer
Garima Sharma et al.
CURRENT GENOMICS (2014)
Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling
Yu Fan et al.
FEBS JOURNAL (2014)
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
Timothy Robert Church et al.
GUT (2014)
Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer
Zhen-Guo Luo et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2014)
MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
Bing Li et al.
LUNG CANCER (2014)
Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report
Tomasz Powrozek et al.
MEDICAL ONCOLOGY (2014)
Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma
Lin Wang et al.
PLOS ONE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
Anthony B. Miller et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
CST6 promoter methylation in circulating cell-free DNA of breast cancer patients
Maria Chimonidou et al.
CLINICAL BIOCHEMISTRY (2013)
SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast Cancer
Maria Chimonidou et al.
CLINICAL CHEMISTRY (2013)
PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy
Yi-Teng Huang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
BRSM1 Promoter Methylation Provides Prognostic Information in Primary Breast Tumors
Maria Chimonidou et al.
MOLECULAR CANCER RESEARCH (2013)
Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
Anastasia A. Ponomaryova et al.
LUNG CANCER (2013)
The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis
Xiang-Bin Xing et al.
PLOS ONE (2013)
Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay
Noriaki Yamamoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma
Jing Shen et al.
EPIGENETICS (2012)
Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals
Hidenori Tani et al.
GENOME RESEARCH (2012)
Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis
Xi Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder Cancer
Y. L. Lin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer
Qifeng Wang et al.
PLOS ONE (2012)
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
Thomas Reinert et al.
PLOS ONE (2012)
Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis
T. Wu et al.
BRITISH JOURNAL OF CANCER (2011)
Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
Jennifer S. McDonald et al.
CLINICAL CHEMISTRY (2011)
Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma
Y. L. Lin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Epithelial-Specific Methylation Marker A Potential Plasma Biomarker in Advanced Non-small Cell Lung Cancer
Chanida Vinayanuwattikun et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
Christoph Kneip et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients
Fernanda Salazar et al.
LUNG CANCER (2011)
Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
Hanyin Cheng et al.
PLOS ONE (2011)
Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing a Blood-Based Test in Breast Cancer
Ramin Radpour et al.
PLOS ONE (2011)
Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression
Gayatri Sharma et al.
TUMOR BIOLOGY (2011)
Correction: Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis
Hector Alvarez et al.
PLoS Genetics (2011)
Molecular Analysis of Plasma DNA for the Early Detection of Lung Cancer by Quantitative Methylation-Specific PCR
Kimberly Laskie Ostrow et al.
CLINICAL CANCER RESEARCH (2010)
DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
N. Shivapurkar et al.
CURRENT MOLECULAR MEDICINE (2010)
Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas
Bo-Lin Liu et al.
NEURO-ONCOLOGY (2010)
Hypomethylation of repeated DNA sequences in cancer
Jason P. Ross et al.
EPIGENOMICS (2010)
Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients
Eiji Sunami et al.
CLINICAL CHEMISTRY (2009)
Sensitive digital quantification of DNA methylation in clinical samples
Meng Li et al.
NATURE BIOTECHNOLOGY (2009)
DNA Methylation Biomarkers of Prostate Cancer: Confirmation of Candidates and Evidence Urine is the Most Sensitive Body Fluid for Non-Invasive Detection
Shannon R. Payne et al.
PROSTATE (2009)
DNA methylation biomarkers for blood-based colorectal cancer screening
Catherine Lofton-Day et al.
CLINICAL CHEMISTRY (2008)
Development of a multiplexed urine assay for prostate cancer diagnosis
Tatiana Vener et al.
CLINICAL CHEMISTRY (2008)
Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma
Han-Shui Hsu et al.
CANCER (2007)
Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA
Shinji Urakami et al.
CLINICAL CANCER RESEARCH (2006)
Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer
Mohammad O. Hoque et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection
Mohammad Obaidul Hoque et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients
Hideharu Kimura et al.
CANCER SCIENCE (2006)
Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation
T. E. Skvortsova et al.
BRITISH JOURNAL OF CANCER (2006)
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
N Yanaihara et al.
CANCER CELL (2006)
p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer
K Kawamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy
T Mori et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
14-3-3σ Methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival:: The Spanish Lung Cancer Group
JL Ramirez et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients
E Dulaimi et al.
CLINICAL CANCER RESEARCH (2004)
Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer
MO Hoque et al.
CANCER RESEARCH (2004)
MethyLight: a high-throughput assay to measure DNA methylation
Cindy A. Eads et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
